AUTHOR=Silva De Castro Isabela , Granato Alessandra , Mariante Rafael Meyer , Lima Marco Antonio , Leite Ana Claudia Celestino , Espindola Otávio de Melo , Pise-Masison Cynthia A. , Franchini Genoveffa , Linden Rafael , Echevarria-Lima Juliana 

TITLE=HTLV-1 p12 modulates the levels of prion protein (PrPC) in CD4+ T cells

JOURNAL=Frontiers in Microbiology

VOLUME=Volume 14 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2023.1175679

DOI=10.3389/fmicb.2023.1175679

ISSN=1664-302X

ABSTRACT=Infection with human T-cell lymphotropic virus type 1 (HTLV-1), is endemic in Brazil and is linked with pro-inflammatory conditions including HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), a chronic neuroinflammatory incapacitating disease that culminates in loss of motor functions. The mechanisms underlying the onset and progression of HAM/TSP are incompletely understood.  Prior studies have demonstrated that inflammation and infectious agents can affect the expression of cellular prion protein (PrPC) in immune cells. Here, we investigated whether HTLV-1 infection affected PrPC content in cell lines and primary CD4+cells in vitro. We found that HTLV-1 infection decreased the expression levels of PrPC and HTLV-1 orf-I encoded p12, an Endoplasmic Reticulum resident protein also known to affect post-transcriptionally cellular proteins such as MHC-class I and the IL-2 receptor. In addition, we observed a reduced percentage of CD4+ T cells from infected individuals expressing PrPC, which was reflected by IFN type II but not IL-17 expression.  These results suggested that PrPC downregulation, linked to both HTLV-1p12 and IFN- expression in CD4+ cells, may play a role in the neuropathogenesis of HTLV-1 infection.